Rigoberto “Gobet” Advincula, a scientist at the Department of Energy’s Oak Ridge National Laboratory, has been named a 2023 Fellow of the National Academy of Inventors. Advincula has been recognized for his 14 patents and 21 published filings related to nanomaterials, smart coatings and films, solid-state device fabrication and chemical additives.
Anne Campbell, a researcher at ORNL, recently won the Young Leaders Professional Development Award from the Minerals, Metals & Materials Society, or TMS, and has been chosen as the first recipient of the Young Leaders International Scholar Program award from TMS and the Korean Institute of Metals and Materials, or KIM.
Michael McGuire’s recognition as the Oak Ridge National Laboratory's top scientist headlined the annual awards. ORNL Director Stephen Streiffer also presented Director’s Awards to two teams, for operational performance and continuous improvement, and to the night’s science communicator awardee
Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.
In the search for ways to fight methylmercury in global waterways, scientists at Oak Ridge National Laboratory discovered that some forms of phytoplankton are good at degrading the potent neurotoxin.
Eric Myers of ORNL has been named a senior member of the Institute of Electrical and Electronics Engineers, effective June 21.
A research team from the Department of Energy’s Oak Ridge and Lawrence Livermore national laboratories won the first Best Open-Source Contribution Award for its paper at the 37th IEEE International Parallel and Distributed Processing Symposium.
Rigoberto Advincula, a renowned scientist at ORNL and professor of Chemical and Biomolecular Engineering at the University of Tennessee, has won the Netzsch North American Thermal Analysis Society Fellows Award for 2023.
Andrew Lupini, a scientist and inventor at ORNL, has been elected Fellow of the Microscopy Society of America.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.